Cannabis has been studied as a potential migraine treatment, and while results are promising, they are often based on self-reported data, small sample sizes, or lack control groups. Further well designed research is needed to establish its efficacy. Below are several summaries of such studies.
D Rhyne et al, 2016, Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population.
In this study, 121 adults suffering from migraine used cannabis daily as a preventive measure. The frequency of migraine attacks reportedly decreased from 10.4 to 4.6 per month. Additionally, almost 40% of the participants reported positive effects, with a decrease in migraine frequency. However, 19.8% reported negative effects, primarily sleepiness and difficulty controlling the timing and intensity of migraines. DOI: 10.1002/phar.1673
E Baron et al, 2018, Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort.
This study explored the use of a combination of THC and CBD for migraine and cluster headache treatment. They found that the THC-CBD combination was slightly better at reducing the frequency of migraine attacks compared to the commonly prescribed migraine drug amitriptyline. However, this effect was only seen in those participants who had migraine since childhood. DOI: 10.1186/s10194-018-0862-2
J Aviram et al, 2020, Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional Study.
In a study exploring the long-term use of cannabis as a treatment for headache and migraine, they found significant improvements in headache and migraine severity after cannabis use. They also noted a decline in the use of other medications, particularly opioids. DOI: 10.3390/brainsci10060360
C Cuttler et al, 2019, Short- and Long-Term Effects of Cannabis on Headache and Migraine.
This research focused on inhaled forms of cannabis. It found that a single inhalation of cannabis could reduce the perceived severity of migraine attacks and headache by nearly 50%. However, the study also noted that cannabis strains with higher levels of THC were more associated with a decrease in pain. DOI: 10.1016/j.jpain.2019.11.001
B Okusanya et al 2022, Medical Cannabis for the treatment of migraine in adults: a review of evidence.
This review collated 12 publications (including Cuttler et al, Rhyne et al cohorts mentioned above) with a total of 1980 participants. It showed some gradience towards symptom relief of migraine headaches with reduced frequency and severity. However, of concern is the reported onset of tolerance to, and medication overuse headaches from medical cannabis after prolonged use. DOI: 10.3389/fneur.2022.871187
While these studies present potential benefits, they also underline the need for more robust, randomised, placebo-controlled trials to establish cannabis efficacy for migraine and to inform standardised treatment protocols. The use of cannabis for migraine should be discussed with a healthcare provider, considering all potential benefits, risks, and individual health circumstances.